Skip to main content

National Diabetes Inpatient Safety Audit

The National Diabetes Inpatient Safety Audit (NDISA) is a subset of the National Diabetes Audit (NDA) and the successor to the NaDIA Bedside and Harms collection. It captures 4 harms that can occur to inpatients with diabetes and seeks to measure the standards of care for these patients provided by NHS acute and community healthcare organisations in England and Wales, as assessed against the Getting it Right First Time (GIRFT) standards

The submission deadline for 2024 - 2025 data will be Thursday 27 November 2025. This covers harms for the period 1 November 2024 – 31 October 2025.

This audit is part of the National Diabetes Audit Programme where you will find information on the legal basis and governance of the audit.


Access the data entry system (CAP)


Dashboard - participation and submission

An annual NDISA dashboard is available from the NDA dashboard hub. This dashboard presents trust and service level participation and submission of harms data as well as information extracted from the Integrated Specialist Services (ISS) survey.

Accessibility of this tool

This tool is in Microsoft PowerBI which does not fully support all accessibility needs. If you need further assistance, please contact us for help.


Overview of the audit

The Department of Health and Social Care directed NHS Digital (now NHS England) to carry out this work in response to concern over the increase in prevalence of diabetes in the population and the associated long-term health implications.

The audit records the details of any adult who has one of four avoidable complications which can occur in inpatients with diabetes.

Linking with other health datasets allows the identification of high-risk demographics which enables the development of proactive processes to reduce the occurrence.

The audit collects data on four harms which can occur to inpatients with diabetes:

Severe inpatient hypoglycaemia

From 1 April 2024, the hypoglycaemia harm criteria will change to a threshold definition: a blood glucose measurement of less than 2.2 mmol/l in a person with diabetes, occurring more than 6 hours into an admission episode, irrespective of treatment regimen and reason for admission.

If multiple qualifying measurements are taken over a short period of time, please limit the hypoglycaemia harm recording to once every 24 hours. Different types of harms may still be recorded within this period.

This change has been made to assist with the automated identification of harms from electronic hospital systems.

There is no change with the way a harm is recorded on the data entry platform.

Diabetic Ketoacidosis (DKA)

Was the patient diagnosed with new onset DKA more than 24 hours after admission?’

DKA requires three key features for diagnosis:

  • known diabetes or blood glucose over 11.0 mmol/l
  • Ketonaemia (blood ketones 3.0 mmol/l or more) or urine ketones 2+ or more
  • Acidosis with venous pH less than 7.3 or bicarbonate less than 15 mmol/l

For more on the definition of DKA please refer to the JBDS guidelines on the ABCD web site.

Hyperglycaemic Hyperosmolar State (HHS)

‘Was the patient diagnosed with new onset HHS more than 24 hours after admission?’

HHS has characteristic features used in its diagnosis:

  • Hypovolaemia
  • marked hyperglycaemia (blood glucose 30 mmol/l or more) without significant ketonaemia (blood ketones less than 3 mmol/l) or acidosis (venous pH 7.3 or more/bicarbonate 15 mmol/l or more)
  • Osmolality usually 320 mosmol/kg or more

For more on the definition of HHS please refer to the JBDS guidelines on the ABCD web site.

Diabetic foot ulcer

‘Was the patient diagnosed with a new onset foot ulcer more than 72 hours after admissions?’

The audit is not intended to collect reports of foot ulcers that are present on admission, or which develop within 3 days of admission. Grade 2+ Pressure sores on the foot that develop more than 72 hours after admission should be included. Deep tissue injury which has not progressed to skin ulceration is not included. Traumatic skin foot lesions and foot infections which arise during the admission are included.

All NHS providers of inpatient care for patients with diabetes in acute settings are expected to participate.


Reports

An annual dashboard as well as a quarterly data quality dashboard can be accessed on the NDA dashboard hub


Patient information

Only hospital or clinic staff with access to the registry can enter patient information. Any treating hospital or clinic can request access for their staff.  

If you are unsure if your information is on the audit, you can submit a subject access request.  

A patient information leaflet is also available to download from the NDA programme page


Data collection

You will need to complete a new registration form for new users to access the Clinical Audit Platform (CAP).

 


Contact us

For further information about the audit, email [email protected].

For general enquiries, email [email protected] call 0300 303 5678 (Monday to Friday 9am to 5pm).


Further information

Last edited: 23 June 2025 2:55 pm